1. Abath, F. G., Coutinho, E. M., Montenegro, S. M., Gomes, Y. M., and Carvalho, A. B., 1988, The use of non-specific immunopotentiators in experimental Trypanosoma cruzi infection, Trans. R. Soc. Trop. Med. Hyg.82: 73–76.
2. Akridge, R. E., Oyafuso, L. K. M., and Reed, S. G., 1994, IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages, J. Immunol.153: 5782–5789.
3. Aldovini, A., and Young, R. A., 1991, Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines, Nature
351: 479–482.
4. Alexander, H. R., Doherty, G. M., Buresh, C. M., Venzon, D. J., and Norton, J. A., 1991, A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice, J. Exp. Med.173: 1029–1032.
5. Ankel, H., Mittnacht, S., and Jacobsen, H., 1985, Antiviral activity of prostaglandin A on encephalomyocarditis virus-infected cells: A unique effect unrelated to interferon, J. Gen. Virol.66: 2355–2364.